FibroScan®
Communiqué de presse | 28.06.2022
Blog et actualités
topic :
category :
statut :
Article | 28.06.2022
Améliorer la prise en charge des patients atteints d’une maladie hépatique avancée grâce à l’évaluation de la rigidité du foie et de la rate
Article | 31.03.2022
Protocole officiel impliquant les infirmiers pour faciliter l’accès au dépistage de la fibrose hépatique
Webinar | 23.03.2022
Diagnostic et prise en charge de la NAFLD/NASH Le point de vue du diabétologue.
Article | 08.03.2022
FibroScan® GO maintenant disponible en France
Communiqué de presse | 28.06.2022
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
Article | 28.06.2022
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
Webinar | 28.06.2022
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
Article | 28.06.2022
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
Article | 28.06.2022
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
Article | 28.06.2022
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
Article | 28.06.2022
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
Communiqué de presse | 28.06.2022
Echosens Highlights New EASL Clinical Practice Guidelines
Article | 28.06.2022
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
Article | 28.06.2022